Loading
A phase 2 trial of penpulimab, cisplatin, carboplatin, pemetrexed and other drugs in lung cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting.
Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043) is a phase 2, randomised interventional study registered as NCT04846634 by Tianjin Medical University Cancer Institute and Hospital, with a registry enrolment figure of 90 participants, started 2021-08 and due to reach its primary completion in 2023-03. Interventions recorded: Penpulimab+Cisplatin/Carboplatin+Pemetrexed/Paclitaxel/Gemcitabine/Docetaxel; Penpulimab+Anlotinib+Cisplatin/Carboplatin+Pemetrexed/Paclitaxel/Gemcitabine/Docetaxel; Penpulimab+Anlotinib. Conditions listed: Resectable Locally Advanced Non-small Cell Lung Cancer. Primary outcome: Major pathological response (MPR). Lung eligibility wording from the registry: "* Early stage IIB-IIIB (N2), operable non-small cell lung cancer, confirmed in tissue". Sites: China. No results are recorded here; the registry entry is the source.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Gemcitabine and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel and the tag lung-deep-dive.
Shares Penpulimab, Anlotinib, Anti-angiogenic therapy, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Cisplatin and the tag lung-deep-dive.
Shares Docetaxel, Pemetrexed, Anti-angiogenic therapy, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents and the tag lung-deep-dive.